S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:CELCCelcuity Stock Price, Forecast & News

$5.90
-0.28 (-4.53 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.70
Now: $5.90
$6.17
50-Day Range
$5.10
MA: $6.05
$7.07
52-Week Range
$4.03
Now: $5.90
$20.86
Volume4,400 shs
Average Volume21,110 shs
Market Capitalization$60.50 million
P/E RatioN/A
Dividend YieldN/A
Beta0.82
Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is developing CELx HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELx MP test to diagnose 12 new potential cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.40 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CELC
CUSIPN/A
Phone763-392-0767

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.88 per share

Profitability

Net Income$-7,360,000.00

Miscellaneous

Employees26
Market Cap$60.50 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$5.90
-0.28 (-4.53 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CELC News and Ratings via Email

Sign-up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Celcuity (NASDAQ:CELC) Frequently Asked Questions

How has Celcuity's stock been impacted by Coronavirus?

Celcuity's stock was trading at $7.12 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CELC stock has decreased by 17.1% and is now trading at $5.90.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Celcuity?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celcuity in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Celcuity
.

When is Celcuity's next earnings date?

Celcuity is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Celcuity
.

How were Celcuity's earnings last quarter?

Celcuity Inc (NASDAQ:CELC) posted its quarterly earnings results on Monday, August, 10th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.03.
View Celcuity's earnings history
.

What price target have analysts set for CELC?

2 Wall Street analysts have issued 1-year price objectives for Celcuity's stock. Their forecasts range from $11.00 to $11.00. On average, they expect Celcuity's stock price to reach $11.00 in the next year. This suggests a possible upside of 86.4% from the stock's current price.
View analysts' price targets for Celcuity
.

Has Celcuity been receiving favorable news coverage?

News headlines about CELC stock have trended negative on Thursday, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Celcuity earned a coverage optimism score of -2.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Celcuity
.

Are investors shorting Celcuity?

Celcuity saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 106,400 shares, a decline of 27.1% from the June 15th total of 146,000 shares. Based on an average daily trading volume, of 31,800 shares, the short-interest ratio is currently 3.3 days. Approximately 2.2% of the shares of the stock are short sold.
View Celcuity's Short Interest
.

Who are some of Celcuity's key competitors?

What other stocks do shareholders of Celcuity own?

Who are Celcuity's key executives?

Celcuity's management team includes the following people:
  • Mr. Brian F. Sullivan, Co-Founder, Chairman & CEO (Age 57)
  • Dr. Lance G. Laing, Co-Founder, Chief Science Officer, VP, Sec. & Director (Age 57)
  • Ms. Vicky Hahne, Chief Financial Officer (Age 53)
  • Ms. Laura Beggrow RN, Chief Commercial Officer (Age 56)
  • Mr. Larry Fitzgerald, VP of Strategic Partnerships & Managed Markets (Age 48)

When did Celcuity IPO?

(CELC) raised $18 million in an initial public offering on Wednesday, September 20th 2017. The company issued 2,000,000 shares at $8.00-$10.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.

What is Celcuity's stock symbol?

Celcuity trades on the NASDAQ under the ticker symbol "CELC."

Who are Celcuity's major shareholders?

Celcuity's stock is owned by a number of institutional and retail investors. Top institutional investors include Gagnon Securities LLC (3.55%), Russell Investments Group Ltd. (1.57%), Gagnon Advisors LLC (1.38%) and UBS Group AG (0.19%).
View institutional ownership trends for Celcuity
.

Which major investors are selling Celcuity stock?

CELC stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG.
View insider buying and selling activity for Celcuity
.

Which major investors are buying Celcuity stock?

CELC stock was bought by a variety of institutional investors in the last quarter, including Gagnon Securities LLC, Russell Investments Group Ltd., and Gagnon Advisors LLC.
View insider buying and selling activity for Celcuity
.

How do I buy shares of Celcuity?

Shares of CELC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Celcuity's stock price today?

One share of CELC stock can currently be purchased for approximately $5.90.

How big of a company is Celcuity?

Celcuity has a market capitalization of $60.50 million. The company earns $-7,360,000.00 in net income (profit) each year or ($0.72) on an earnings per share basis. Celcuity employs 26 workers across the globe.

What is Celcuity's official website?

The official website for Celcuity is www.celcuity.com.

How can I contact Celcuity?

Celcuity's mailing address is 16305 36TH AVENUE NORTH SUITE 100, MINNEAPOLIS MN, 55446. The company can be reached via phone at 763-392-0767.

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.